Option chain shows key data for Algorae Pharmaceuticals's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Algorae Pharmaceuticals.

Algorae Pharmaceuticals (OTC:LVCLF) Stock, Option Chain

Algorae Pharmaceuticals Ltd is a clinical-stage pharmaceutical company developing transformative solutions for under met medical needs in the community. The firm develops AlgoraeOS, a closed-loop platform, leveraging computational tools to generate novel insights in silico that are being developed to initiate or accelerate therapeutic programs. The products of the company comprise AI-116, a novel combination drug candidate of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. The company is conceptualized to be a potential treatment for dementia, including Alzheimer's disease, NTCELL is an alginate-coated capsule containing clusters of neonatal porcine choroid plexus cells. It also offers LP-003 Anti-obesity Drug and LC-002 migraine treatment.

ALGORAE PHARMACETICLS LTD by ALGORAE PHARMACEUTICALS LTD.

Algorae Pharmaceuticals Ltd

Living Cell Technologies Ltd. (AU:1AI) has released an update. Algorae Pharmaceuticals Ltd. announces the successful launch of its AI-driven platfo...

Algorae Pharmaceuticals Unveils AI-Driven Drug Discovery Platform

Living Cell Technologies Ltd. (AU:1AI) has released an update. Algorae Pharmaceuticals has successfully launched its AI platform, AlgoraeOS, which ...

Algorae Pharmaceuticals Launches AI Platform and Advances Drug Trials

Living Cell Technologies Ltd. (AU:1AI) has released an update. Algorae Pharmaceuticals Limited is making strides in drug development with the launc...

Algorae Pharmaceuticals Boosts Drug Development with AI

Living Cell Technologies Ltd. (AU:1AI) has released an update. Algorae Pharmaceuticals Limited has announced the successful outcome of its Annual G...

Algorae Pharmaceuticals Secures Shareholder Support at AGM

Living Cell Technologies Ltd. (AU:1AI) has released an update. Algorae Pharmaceuticals Limited has announced a proposal to issue 40 million perform...

Algorae Pharmaceuticals Plans Major Securities Issuance

Living Cell Technologies Ltd. (AU:1AI) has released an update. Algorae Pharmaceuticals has ceased its American Depositary Share program on the OTCQ...

Algorae Pharmaceuticals Streamlines Operations with OTCQB Exit

Living Cell Technologies Ltd. (AU:1AI) has released an update. Algorae Pharmaceuticals Limited has announced a proposed issuance of 23,890,665 opti...

Living Cell Technologies Ltd. (AU:1AI) has released an update. Algorae Pharmaceuticals has expanded its therapeutic pipeline with 24 new AI-generat...

Algorae Pharmaceuticals Expands Pipeline with AI-Driven Targets

Living Cell Technologies Ltd. (AU:1AI) has released an update. Algorae Pharmaceuticals has appointed Dr. Sarah Siggins to its Scientific Advisory B...

Algorae Pharmaceuticals Strengthens Board with Industry Expert

Living Cell Technologies Ltd. (AU:1AI) has released an update. Algorae Pharmaceuticals has announced promising preclinical results for its drug can...

Comments

Algorae Pharmaceuticals

Algorae Pharmaceuticals (LVCLF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga